About BIFORMYX BIOPHARMA INC.
BiFormyx BioPharma is a biotechnology company focused on developing dual-payload antibody-drug conjugates (DualADCs) to target aggressive solid tumors with high unmet medical need. Their platform delivers two distinct therapeutic payloads directly to cancer cells using proprietary linker combinations and tumor-specific targeting moieties.
Is this your company?
Claim BIFORMYX BIOPHARMA INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim BIFORMYX BIOPHARMA INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.